The Pharmacist e-Link™ Continuing Education Center is designed to provide you with expanded online access to the highest quality of continuing education on a complimentary basis, through the convenience of the MyCECity™ Online Learning Management System.

Need help logging into the Pharmacist e-Link site? Click here for Registration and Login information.

Pharmacist e-Link CE Spotlight

Bioequivalence, Therapeutic Equivalence, & Clinical Case Management in Thyroid Disease

Studies consistently show that as many as 40% of patients with hypo- or hyper-thyroidism are not well managed by physicians. These studies each used thyroid-stimulating hormone (TSH) as the clinical marker of thyroid dysfunction. Studies have also shown that the clinical consequences of abnormal TSH levels include cardiovascular and lipid risks; miscarriage, fetal death and lower IQs; and particular risks for patients with cancer.

This program is supported by an educational grant from Abbott Laboratories.

Other Featured CE

New and Spotlighted Programs in the Pharmacist e-Link Library
Click the activity title below to login and enter the activity.

	A Pharmacist's Guide to Counterfeit Prevention Reports of counterfeit medications infiltrating the distribution chain have become widespread and undermine the confidence of patients in the medications they are taking, their physician, and pharmacist. It is estimated that five to eight percent of drugs worldwide are counterfeit. The program is supported by an educational grant from Pfizer, Inc.
	Every Breath You Take: Moving Towards Better COPD Management It is estimated that chronic obstructive pulmonary disease affects 16 million Americans, and the direct and indirect annual cost of the disease is approximately 32 billion dollars. COPD is currently considered to be the fourth leading cause of death in the USA, and it is the only one in the top 5 causes of death that continues to increase annually. This program is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Pfizer, Inc.
	Surviving the First Six Months of Medicare – aka: "Help! The Sky is Really Falling" This timely program will provide pharmacists with the tools they need to survive the first six months of Medicare. Additionally, it will highlight areas of professional and business opportunities to make the best of the new Medicare benefit for 2006 and beyond. This program is supported by an educational grant from Merck & Co., Inc.
	Migraine Prevention Each year more than 25 million Americans, representing at least 12% of the adult population, suffer from severe migraines. Accurately identifying the shifting diagnostic criteria that pertain to chronic migraine is important, as is a review of drug protocols for prophylaxis therapy. This activity is supported by an educational grant from Ortho-McNeil Neurologics.
	Newer Options in the Management of Type 2 Diabetes: The Role of Incretin Mimetics The goal of this educational activity is to provide an overview of the clinical potential of incretin mimetics in the management of patients with type 2 diabetes. Supported by an educational grant from Amylin Pharmaceuticals and Eli Lilly and Company.

Pharmacist e-Link CE Spotlight is sent by Pharmacist e-Link™, located at
307 Seventh Avenue, 24th Floor, New York, NY 10001.
Pharmacist e-Link never sends unsolicited mail.
If you wish to unsubscribe from further mailings, please click here.